US WorldMeds
US WorldMeds Completes Phase III Trial of Lofexidine for Treatment of Opiate Withdrawal Symptoms
Published in Medical Letter on the CDC and FDA, July 13th, 2008
US WorldMeds, a Kentucky-based specialty pharmaceutical company, announced that a recently completed Phase III clinical trial investigating the use of lofexidine hydrochloride (Lofexidine) for the treatment of opiate withdrawal symptoms in patients undergoing opiate detoxification has shown that opiate-dependent patients taking the drug experienced a significant reduction in withdrawal symptoms at the anticipated peak of withdrawal and stayed longer in detoxification treatment as compared to patients taking placebo.
"The debilitating withdrawal symptoms associated with opiate detoxification are a major reason people struggling with heroin or prescription drug addiction...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- University of California - Santa Barbara
Diversity among bird populations found to reduce threat of West Nile virus - Gene Therapy
Scientists at Nanyang Technological University publish new data on gene therapy - HIV/AIDS
Findings from University of Ghent broaden understanding of HIV/AIDS - HIV/AIDS
Report summarizes HIV/AIDS study findings from Johns Hopkins University - Life Sciences
Researchers from Food & Drug Administration report recent findings in life sciences - Medtronic, Inc.
Medtronic Receives FDA Approval of Industry's First Active Fixation Left-Heart Cardiac Resynchronization Lead - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
